Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10005041HBVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS10005042HBVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS10034071HBVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS10051034HBVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS10050959HBVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS30086592HIVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS30086040HIVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS30083783HIVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS30063832HIVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS30063833HIVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TCGA Plot Options
Drug Information
GeneGRIA1
DrugBank IDDB09289
Drug NameTianeptine
Target IDBE0000640
UniProt IDP42261
Regulation Typemodulator
PubMed IDs19704408
CitationsMcEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E: The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010 Mar;15(3):237-49. doi: 10.1038/mp.2009.80. Epub 2009 Aug 25.
GroupsInvestigational
Direct ClassificationMedium-chain fatty acids
SMILESCN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Pathways
PharmGKB
ChEMBLCHEMBL1289110